Suppr超能文献

与端粒长度较长相关的遗传变异与肾细胞癌风险增加相关。

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

International Agency for Research on Cancer (IARC), Lyon, France.

出版信息

Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7.

Abstract

BACKGROUND

Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings.

OBJECTIVE

We performed an analysis of genetic variants associated with leukocyte telomere length to assess the relationship between telomere length and RCC risk using Mendelian randomization, an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations.

DESIGN, SETTING, AND PARTICIPANTS: Genotypes from nine telomere length-associated variants for 10 784 cases and 20 406 cancer-free controls from six genome-wide association studies (GWAS) of RCC were aggregated into a weighted genetic risk score (GRS) predictive of leukocyte telomere length.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Odds ratios (ORs) relating the GRS and RCC risk were computed in individual GWAS datasets and combined by meta-analysis.

RESULTS AND LIMITATIONS

Longer genetically inferred telomere length was associated with an increased risk of RCC (OR=2.07 per predicted kilobase increase, 95% confidence interval [CI]:=1.70-2.53, p<0.0001). As a sensitivity analysis, we excluded two telomere length variants in linkage disequilibrium (R>0.5) with GWAS-identified RCC risk variants (rs10936599 and rs9420907) from the telomere length GRS; despite this exclusion, a statistically significant association between the GRS and RCC risk persisted (OR=1.73, 95% CI=1.36-2.21, p<0.0001). Exploratory analyses for individual histologic subtypes suggested comparable associations with the telomere length GRS for clear cell (N=5573, OR=1.93, 95% CI=1.50-2.49, p<0.0001), papillary (N=573, OR=1.96, 95% CI=1.01-3.81, p=0.046), and chromophobe RCC (N=203, OR=2.37, 95% CI=0.78-7.17, p=0.13).

CONCLUSIONS

Our investigation adds to the growing body of evidence indicating some aspect of longer telomere length is important for RCC risk.

PATIENT SUMMARY

Telomeres are segments of DNA at chromosome ends that maintain chromosomal stability. Our study investigated the relationship between genetic variants associated with telomere length and renal cell carcinoma risk. We found evidence suggesting individuals with inherited predisposition to longer telomere length are at increased risk of developing renal cell carcinoma.

摘要

背景

在几项研究中,外周血白细胞中的相对端粒长度已被评估为肾细胞癌 (RCC) 风险的潜在生物标志物,但研究结果存在冲突。

目的

我们分析了与白细胞端粒长度相关的遗传变异,以使用孟德尔随机化评估端粒长度与 RCC 风险之间的关系,这种方法不受时间变异性和反向因果关系偏倚的影响,而这些偏倚可能会影响早期的研究。

设计、地点和参与者:对来自六个 RCC 全基因组关联研究 (GWAS) 的 10784 例病例和 20406 例无癌症对照的 9 个端粒长度相关变异的基因型进行了汇总,形成了一个可预测白细胞端粒长度的加权遗传风险评分 (GRS)。

结局测量和统计分析

在个体 GWAS 数据集中计算了与 GRS 和 RCC 风险相关的比值比 (OR),并通过荟萃分析进行了合并。

结果和局限性

遗传推断的端粒长度越长,RCC 的风险就越高(每个预测千碱基增加的 OR=2.07,95%置信区间 [CI]:1.70-2.53,p<0.0001)。作为敏感性分析,我们从端粒长度 GRS 中排除了两个与 GWAS 确定的 RCC 风险变异(rs10936599 和 rs9420907)处于连锁不平衡 (R>0.5) 的端粒长度变异(rs10936599 和 rs9420907);尽管排除了这两个变异,但 GRS 与 RCC 风险之间仍然存在统计学显著的关联(OR=1.73,95% CI=1.36-2.21,p<0.0001)。对个体组织学亚型的探索性分析表明,与端粒长度 GRS 对透明细胞(N=5573,OR=1.93,95% CI=1.50-2.49,p<0.0001)、乳头状(N=573,OR=1.96,95% CI=1.01-3.81,p=0.046)和嫌色细胞 RCC(N=203,OR=2.37,95% CI=0.78-7.17,p=0.13)具有类似的关联。

结论

我们的研究结果进一步证明了端粒长度较长的某个方面对 RCC 风险很重要。

患者总结

端粒是染色体末端的 DNA 片段,可维持染色体稳定性。我们的研究调查了与端粒长度相关的遗传变异与肾细胞癌风险之间的关系。我们发现的证据表明,具有较长端粒遗传倾向的个体发生肾细胞癌的风险增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b38/5641242/8395a2ccca64/nihms898474f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验